Jupiter Medical Center Earns National Recognition for Orthopedics: Earns 5 Highly Coveted Accreditations by BC BS Association

Jupiter Medical Center, ranked number one for safety, quality and patient satisfaction in Palm Beach County and the Treasure Coast region, today announced it has been selected as a Blue Distinction Center+ for Total Hip & Knee Replacement, and Spine Surgery, as well as receiving The Gold Seal of Approval® from The Joint Commission for Total Hip & Knee Replacement, Total Shoulder Replacement, and Spine Surgery.

Jupiter Medical Center is the only hospital in the state of Florida to earn all five highly coveted accreditations, a designation awarded by the Blue Cross and Blue Shield Association for delivering exceptional care and results for patients undergoing these orthopedic surgeries.

The orthopedic program at Jupiter Medical Center provides world-class care to patients who come from all parts of the country to receive the best outcomes possible,” said Dr. Amit Rastogi, president and CEO of Jupiter Medical Center. “It’s an honor to be recognized for meeting the vigorous criteria for outstanding orthopedic care set by both the prestigious The Joint Commission and the Blue Distinction Specialty Care program.”

The Joint Commission is the recognized global leader for health care accreditation. The independent, not-for-profit organization examines a hospital’s quality achievement in patient care and safety and establishes the most rigorous standards to raise the bar among health care providers globally. Furthermore, Blue Distinction Centers® are nationally designated healthcare facilities that demonstrate a commitment to delivering high-quality patient safety and better health outcomes, based on objective measures that were developed with input from the medical community and leading accreditation and quality organizations.

Jupiter Medical Center takes a coordinated and comprehensive approach to orthopedic care, delivered by an expert, multidisciplinary team of surgeons, physical therapists and other skilled clinicians. The Anderson Family Orthopedic & Spine Center at Jupiter Medical Center has long been at the forefront of joint replacement and spine care, providing innovative and high-quality diagnosis and treatment.

As a Blue Distinction Center for Knee and Hip Replacement, Jupiter Medical Center is recognized for its expertise in total knee and hip replacement surgeries, including assessments of patients’ physical abilities after surgery, known as “functional outcomes.” Blue Distinction Centers+ is an additional designation recognizing Jupiter Medical Center’s performance on measures of cost-effectiveness and affordability, such as lower complication rates and fewer hospital readmissions.

Jupiter Medical Center has also invested in innovative technologies that offer less invasive treatment options, better results, and speedier recovery times. The hospital recently enhanced its total knee replacement capabilities with Mako Robotic-Arm Assisted Technology. The Mako Robotic-Arm creates a 3D virtual model of the patient’s bone anatomy, allowing medical teams to place implants virtually, prior to surgery. Once the surgical team is satisfied with the virtual model, they can use the Mako to proceed with surgery. This allows for more precise bone preparation, less soft tissue injury, and the potential for less pain and a speedier recovery. The Mako is also used for partial knee and hip replacements, and total hip replacements.

“Implementing new technologies, such as the Mako for knee and hip replacements, is just one example of our ongoing efforts to enhance patient care and help our patients get back to enjoying their lives without pain or mobility limitations,” Dr. Rastogi said.

Facilities designated as Blue Distinction Centers® for Spine Surgery demonstrate expertise in cervical and lumbar fusion, cervical laminectomy and lumbar laminectomy/discectomy procedures, resulting in fewer patient complications and readmissions compared to other facilities. Additionally, to meet The Joint Commission’s certification for spine surgery, providers must meet three core requirements: standards, clinical practice guidelines, and performance measurement.

Dr. Rastogi says, “To be the only hospital in the state to earn all of these highly coveted awards for quality and safety, is an accomplishment earned by the expertise of the entire orthopedic team, and our focus on minimally invasive techniques and reducing patient recovery times.”

Jupiter Medical Center

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version